CN1287853A - Bolus for bone setting and activating collaterals - Google Patents
Bolus for bone setting and activating collaterals Download PDFInfo
- Publication number
- CN1287853A CN1287853A CN99118767A CN99118767A CN1287853A CN 1287853 A CN1287853 A CN 1287853A CN 99118767 A CN99118767 A CN 99118767A CN 99118767 A CN99118767 A CN 99118767A CN 1287853 A CN1287853 A CN 1287853A
- Authority
- CN
- China
- Prior art keywords
- radix
- bolus
- draconis
- activating collaterals
- angelicae sinensis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A medicinal pill for treating bone fracture and traumatic injury is prepared from cornu cervi pantotrichum 70-110 g., drynaria rhizome 30-50 g., resina draconis 80-100 g., flos carthami 15-20 g, radix dipsaic 20-30 g, radix notoginseng 20-30 g., radix angelicae sinensis 20-30g., os draconis 30-50 g., eupolyphaga seu steleophaga 10-20 g., lignum aquilariae resinatum 5-10 g. and rhubarb 10-25g. Its effective rate can be 100% and it has no toxic side effect.
Description
The present invention relates to A61K 9/20 class, a kind of oral water pill that is used for the treatment of fracture, traumatic injury.
In motherland's traditional medicine, the medicament of treatment traumatic injury is too numerous to enumerate.But along with the raising of medical advance, medical level, the curative effect of this class medicine, particularly oral administration pills is differentiated, made pottery and eliminate day by harsh, general traditional prescription is under suspicion.Doctors and patients press for the synthetism oral medicine of more remarkable treatment effect.
The purpose of this invention is to provide a kind of evident in efficacy, oral agents that can shorten the course of treatment, bolus for bone setting and activating collaterals.
Component proportioning of the present invention is:
Cornu Cervi Pantotrichum 70-110g, Rhizoma Drynariae 30-50g, Sanguis Draxonis 80-100g, Flos Carthami 15-20g, Radix Dipsaci 20-30g, Radix Notoginseng 20-30g, Radix Angelicae Sinensis 20-30g, Os Draconis 40-50g, Eupolyphaga Seu Steleophaga 10-20g, Lignum Aquilariae Resinatum 5-10g, Radix Et Rhizoma Rhei 10-25g.
Cure mainly function: reunion of fractured tendons and bones, blood circulation promoting and blood stasis dispelling, treatment miscellaneous fracture, dislocation and traumatic injury.
Bolus for bone setting and activating collaterals of the present invention through clinical observation two over thousands of routine patients, is learned processing by statistics and is drawn as drawing a conclusion: effective percentage 100%, cure rate 96.4%.General fracture is visible obvious curative effects after medication all around, compares with existing oral medicine, can shorten the course of treatment 1/4 even 1/3.And under observation do not find the toxic and side effects of this medicine.
Embodiment:
Bolus for bone setting and activating collaterals cures mainly function: reunion of fractured tendons and bones, blood circulation promoting and blood stasis dispelling, treatment miscellaneous fracture, dislocation and traumatic injury.
Example 1: the dosage form that the adult takes is characterized in that the proportioning of medicament is: Cornu Cervi Pantotrichum 70g, Rhizoma Drynariae 40g, Sanguis Draxonis 100g, Flos Carthami 15g, Radix Dipsaci 30g, Radix Notoginseng 25g, Radix Angelicae Sinensis 25g, Os Draconis 40g, Eupolyphaga Seu Steleophaga 15g, Lignum Aquilariae Resinatum 8g, Radix Et Rhizoma Rhei 25g.
The dosage form of children taking, the proportioning of medicament can also be: Rhizoma Drynariae 30g, Sanguis Draxonis 80g, Flos Carthami 15g, Radix Dipsaci 20g, Radix Notoginseng 20g, Radix Angelicae Sinensis 20g, Os Draconis 50g, Eupolyphaga Seu Steleophaga 10g, Lignum Aquilariae Resinatum 5g.
The dosage form that the old people takes, the proportioning of medicament can also be: Cornu Cervi Pantotrichum 110g, Rhizoma Drynariae 50g, Sanguis Draxonis 100g, Flos Carthami 20g, Radix Dipsaci 30g, Radix Notoginseng 30g, Radix Angelicae Sinensis 30g, Os Draconis 50g, Eupolyphaga Seu Steleophaga 20g, Lignum Aquilariae Resinatum 10g, Radix Et Rhizoma Rhei 10g.
The preparation of pill: by the mechanical general ball explained hereafter in pharmaceutical factory, with raw material pulverizing, sieve, use sweet water pill, drying, coating, packing, every bottle of 50g.
Usage and dosage: every day three times, each 5 grams, warm water takes.
The consumption of old fracture is 1.5 times of convention amount.
The effect contrast:
The curative effect comparision treatment group Orally taken fracture setting of bolus for bone setting and activating collaterals and the synthetism Anisodus carniolicoides C.Y.Wu et C.Chen network ball that relaxes, matched group Orally taken fracture setting Anisodus carniolicoides C.Y.Wu et C.Chen.
Table 1 age distribution situation group 18-30 year 31-40 year 41-50 year 61-60 year add up to (%) treatment to organize 7 people, 28 4 people, 16 4 people, 16 10 people, 40 25 100 matched groups, 35 people, 35 17 people, 17 16 people, 16 40 people 40 100 100 and add up to % 42 33.6 21 16.8 27 21.60 35 28.00 125 100
Table 2 sex distribution situation not other treatment groups of surname (%) matched group (%) adds up to (%) man 12 48.00 57 57.00 69 55.20 woman 13 52.00 43 43.00 56 44.80 to add up to 25 100 100 125 100
Table 3 fracture site distribution situation position treatment group (%) control group (%) adds up to (routine %) clavicle 1 4.00 9 9.00 10 8.00 humerus 1 4.00 12 12.00 13 10.40 chis to scratch bone 3 12.00 14 14.00 17 13.60 distal radius 7 28.00 27 27.00 34 27.20 metacarpal-phalangeals 5 20.00 4 4.00 9 7.20 fibulas 5 20.00 17 17.00 22 17.60 tarsometatarsus bones 6 24.00 2 2.00 8 6.40
Clinical efficacy compares group n clinical cure produce effects enabledisable effective rates group 25 21 22 100% matched groups 100 54 23 18 5 97.00 between table 4 liang group
The clinical healing standard of fracture: local no tenderness, there is not vertical percussion pain; Local no abnormal moving; The X skiagram shows that fracture line is fuzzy, has seriality arm coffee to pass through fracture line.Functional examination: removing under the external fixation situation, upper limb can be put down act 1Kg weight and be reached 1 minute, the continuous pad it of lower limb energy 3 minutes, and be no less than for 30 steps; Observed for 2 weeks continuously; Fracture is indeformable, is the clinical healing date in the 1st day that then observes.
The curative effect judgment criteria:
Clinical cure: healing time reaches clinical healing standard person in advance than traditional standard more than 1/3.
Produce effects: healing time shifts to an earlier date 1/3-1/4 and reaches clinical healing standard person.
Effectively: healing time shifts to an earlier date 1/4-1/4 and reaches clinical healing standard person.
Invalid: healing time is identical with the healing time of taking the synthetism Anisodus carniolicoides C.Y.Wu et C.Chen.
Claims (4)
1, a kind of bolus for bone setting and activating collaterals is used for the treatment of the oral water pill of fracture, traumatic injury, it is characterized in that the component proportioning of medicament is:
Cornu Cervi Pantotrichum 70-110g, Rhizoma Drynariae 30-50g, Sanguis Draxonis 80-100g, Flos Carthami 15-2g, Radix Dipsaci 20-3g, Radix Notoginseng 20-30g, Radix Angelicae Sinensis 20-3g, Os Draconis 40-5g, Eupolyphaga Seu Steleophaga 10-20g, Lignum Aquilariae Resinatum 5-1g, Radix Et Rhizoma Rhei 10-25g.
2, bolus for bone setting and activating collaterals according to claim 1, the dosage form that the adult takes is characterized in that the proportioning of medicament is: Cornu Cervi Pantotrichum 70g, Rhizoma Drynariae 40g, Sanguis Draxonis 100g, Flos Carthami 15g, Radix Dipsaci 30g, Radix Notoginseng 25g, Radix Angelicae Sinensis 25g, Os Draconis 40g, Eupolyphaga Seu Steleophaga 15g, Lignum Aquilariae Resinatum 8g, Radix Et Rhizoma Rhei 25g.
3, bolus for bone setting and activating collaterals according to claim 1, the dosage form of children taking is characterized in that the proportioning of medicament can also be: Rhizoma Drynariae 30g, Sanguis Draxonis 80g, Flos Carthami 15g, Radix Dipsaci 20g, Radix Notoginseng 20g, Radix Angelicae Sinensis 20g, Os Draconis 50g, Eupolyphaga Seu Steleophaga 10g, Lignum Aquilariae Resinatum 5g.
4, bolus for bone setting and activating collaterals according to claim 1, the dosage form that the old people takes is characterized in that the proportioning of medicament can also be: Cornu Cervi Pantotrichum 110g, Rhizoma Drynariae 50g, Sanguis Draxonis 100g, Flos Carthami 20g, Radix Dipsaci 30g, Radix Notoginseng 30g, Radix Angelicae Sinensis 30g, Os Draconis 50g, Eupolyphaga Seu Steleophaga 20g, Lignum Aquilariae Resinatum 10g, Radix Et Rhizoma Rhei 10g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB991187679A CN1157198C (en) | 1999-09-10 | 1999-09-10 | Bolus for bone setting and activating collaterals |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB991187679A CN1157198C (en) | 1999-09-10 | 1999-09-10 | Bolus for bone setting and activating collaterals |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1287853A true CN1287853A (en) | 2001-03-21 |
| CN1157198C CN1157198C (en) | 2004-07-14 |
Family
ID=5280536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB991187679A Expired - Fee Related CN1157198C (en) | 1999-09-10 | 1999-09-10 | Bolus for bone setting and activating collaterals |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1157198C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101843799B (en) * | 2009-11-25 | 2011-07-27 | 北京绿源求证科技发展有限责任公司 | Oral Chinese medicament for treating fracture |
| CN101843798B (en) * | 2009-10-28 | 2011-07-27 | 北京绿源求证科技发展有限责任公司 | Oral Chinese medicament for treating fracture |
-
1999
- 1999-09-10 CN CNB991187679A patent/CN1157198C/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101843798B (en) * | 2009-10-28 | 2011-07-27 | 北京绿源求证科技发展有限责任公司 | Oral Chinese medicament for treating fracture |
| CN101843799B (en) * | 2009-11-25 | 2011-07-27 | 北京绿源求证科技发展有限责任公司 | Oral Chinese medicament for treating fracture |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1157198C (en) | 2004-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101062372A (en) | Chinese herbal medicine preparation for dissolving hepatobiliary system calculi | |
| CN101066421A (en) | Plaster for treating cholecystitis, cholangitis and bile gastritis | |
| CN1079152A (en) | Preparation method of quick-acting bone injury medicine | |
| CN1907410A (en) | Chinese traditional medicine preparation for treating bone fracture and traumatic injury | |
| CN1823972A (en) | Medicine for treating celevical vertebra disease | |
| CN103656325B (en) | A kind of otch nursing thing for the treatment of postoperative wound and doing not feel like oneself | |
| CN1129130A (en) | Medicament for treatment of cervical spondylopathy | |
| CN103027978A (en) | Medicine composition for treating traumatic injury and preparation method of medicine composition | |
| CN1183930C (en) | Bone-setting medicine and its preparing process | |
| CN1160091C (en) | Medicine for treating ophthalmopathy | |
| CN1157198C (en) | Bolus for bone setting and activating collaterals | |
| CN101161276B (en) | Spray for treating exogenous injury, empyrosis and bone fracture as well as its preparing method | |
| CN1324650A (en) | Effective medicine for treating cervical vertebra disease as one kind of intractable disease | |
| CN101259200B (en) | Orally-administered and externally-applied specific medicine for treating bone injury disease, protrusion of lumbar intervertebral discs and wrick | |
| CN1185007C (en) | Blood-lipid-reducing thrombolytic medicine | |
| CN1229118C (en) | Bone setting medicine | |
| CN101181441B (en) | Medicament for curing gonad progeria as well as preparation technique thereof | |
| CN1069039C (en) | Panacea oinment | |
| CN1090196A (en) | Liquid for curing bone fracture | |
| CN103705777B (en) | A kind of treat postoperative wound do not feel like oneself otch nursing medicated powder preparation method | |
| CN1326548C (en) | Medicine for treating gonorrhoea | |
| CN1236798C (en) | External medicine for treating bone tuberculosis | |
| CN101530448A (en) | External Chinese medicinal plaster for treating traumatic injury | |
| CN101099773A (en) | Hyperosteogeny-treating plaster | |
| CN1390600A (en) | Medicine for treating gastritis and gastric or duodenal ulcer and its preparing process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |